908-full
msladyinca
Sex: F
Data Quality: 2 stars
MS: 38 yrs
Mentor
Type: Secondary Progressive
Sensation: None
Overall: Mild
Cognition: none
Vision: none
Speech: none
Swallowing: none
Upper limb: moderate
Walking: severe
msladyinca
Female, 58 years
CA, United States
Primary Condition
MS
Type
Secondary Progressive
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

msladyinca's Copaxone is for:

  • Other
  • MS

msladyinca's side effects of Copaxone:

msladyinca's Copaxone History (Stopped)
Copaxone (glatiramer acetate)
Jun 02, 2004 - Jan 01, 2005
Stopped Did not seem to work Jan 01, 2005
Evaluations
Date Dosage Other Perceived effectiveness MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Jan 01, 2005 Led_efficacy_1Led_defaultLed_defaultLed_default Led_efficacy_1Led_defaultLed_defaultLed_default SevereSevereSevereSevere UsuallyUsuallyUsuallyUsually VeryVeryVeryVery
Date
Jan 01, 2005
Advice & Tips
Take the medication out of the refrigerator a couple of hours before you inject it. Ice the injection site approximately 5 minutes before you inject (place an ice cube in a washcloth and hold it against the skin). Also, take a couple of ibuprofen approximately 20 minutes before you inject as this will help with the pain from the injection. In addition, if using an auto injector, don't press the injector to hard against the skin as this will cause a welt to develop because the medication has nowhere to go. Lastly, use the palm of your hand to massage the area after you inject so as to help disperse the medication.

About Copaxone (Prescription Drug)

Copaxone®, a brand name of glatiramer acetate, combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection. Read more...Click to read more below

Learn more about Copaxone in our Copaxone Community Report.